It usually over-expresses in patients’ tumors and metastases, and the over-expression of lncRNA MALAT1 has been shown to be positively correlated with tumor progression and metastasis in a large number of tumor types, including breast tumors [16, 17]. This evidence concerns the gene MALAT1 and breast neoplasm.